MedPath
FDA Approval

Olanzapine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 3, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Olanzapine(10 mg in 2 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aspiro Pharma Limited

Camber Pharmaceuticals, Inc.

872341023

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Olanzapine

Product Details

NDC Product Code
31722-308
Application Number
ANDA217466
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR
Effective Date
April 3, 2023
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACTQuantity: 50 mg in 2 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: N7U69T4SZRClass: ACTIBQuantity: 10 mg in 2 mL
TARTARIC ACIDInactive
Code: W4888I119HClass: IACTQuantity: 3.5 mg in 2 mL
© Copyright 2025. All Rights Reserved by MedPath